Is a complete BCBA/AMGN research report available?

No complete published report is available for bcba/AMGN (BCBA/AMGN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/AMGN (BCBA/AMGN)

Buenos Aires Stock Exchange: BCBA/AMGN · ARS

ARS 24,910

+270.00 (+1.1%)· Recorded snapshot

Market cap	375.5T
Revenue (ttm)	56.4T
Net income (ttm)	13T
EPS (ttm)	ARS 827
P/E (trailing)	30.1x
P/E (forward)	19.0x
Dividend	ARS 307 (1.23%)
Volume	1,008
Beta	0.41

Market data

Price

Recent price action with selectable time range.

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-11-03
Employees	31,500
Employees change	1,300
Employees growth	4.87%
Enterprise value	ARS 442.1T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1980
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	ARDEUT110665
Last earnings date	2026-08-04
Last refreshed	2026-10-29
Last stock split date	2024-01-24
Last stock split type	Forward
Market cap	ARS 375.5T
Next earnings date	2026-11-03
Price	ARS 24,910.00
Price currency	ARS
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	bcba/AMGN
Website	https://www.amgen.com

Metric

Value

Amount currency

ARS

Country

United States

Country code

Earnings date

2026-11-03

Employees

31,500

Employees change

1,300

Employees growth

4.87%

Enterprise value

ARS 442.1T

Exchange

Buenos Aires Stock Exchange

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

December

Founded

1980

Industry

Drug Manufacturers - General

Is primary listing

ISIN number

ARDEUT110665

Last earnings date

2026-08-04

Last refreshed

2026-10-29

Last stock split date

2024-01-24

Last stock split type

Forward

Market cap

ARS 375.5T

Next earnings date

2026-11-03

Price

ARS 24,910.00

Price currency

ARS

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

bcba/AMGN

Website

https://www.amgen.com

Metric	Value
Average P/E ratio (10Y)	25.24x
Average P/E ratio (3Y)	29.44x
Average P/E ratio (5Y)	25.49x
Earnings yield	3.32%
EV/Earnings	34.13x
EV/EBIT	22.6x
EV/EBITDA	16.41x
EV/FCF	29.33x
EV/Sales	7.55x
FCF / EV yield	3.41%
FCF yield	4.01%
Forward P/E	19.05x
Graham number	4711.9784
Graham upside	-81.08%
Lynch fair value	ARS 7,524.01
Lynch upside	-69.8%
P/(FCF - SBC) ratio	26.18x
P/(OCF - SBC) ratio	21.15x
P/B ratio	21.69x
P/E ratio	30.12x
P/FCF ratio	24.91x
P/OCF ratio	20.32x
P/S ratio	6.65x
Price/EBITDA ratio	14.68x

Metric

Value

Average P/E ratio (10Y)

25.24x

Average P/E ratio (3Y)

29.44x

Average P/E ratio (5Y)

25.49x

Earnings yield

3.32%

EV/Earnings

34.13x

EV/EBIT

22.6x

EV/EBITDA

16.41x

EV/FCF

29.33x

EV/Sales

7.55x

FCF / EV yield

3.41%

FCF yield

4.01%

Forward P/E

19.05x

Graham number

4711.9784

Graham upside

-81.08%

Lynch fair value

ARS 7,524.01

Lynch upside

-69.8%

P/(FCF - SBC) ratio

26.18x

P/(OCF - SBC) ratio

21.15x

P/B ratio

21.69x

P/E ratio

30.12x

P/FCF ratio

24.91x

P/OCF ratio

20.32x

P/S ratio

6.65x

Price/EBITDA ratio

14.68x

Metric	Value
EBIT margin	33.4%
EBITDA margin	45.33%
Effective tax rate	15.01%
FCF margin	25.67%
Gross margin	71.89%
Operating margin	33.4%
Pretax margin	27%
Profit margin	22.95%
Profit per employee	ARS 411.2M
Profitable quarters	9
Profitable years	23
Revenue per employee	ARS 1.8B
ROA	8.67%
ROA (5Y)	8.22%
ROCE	18.14%
ROE	91.47%
ROE (5Y)	101.82%
ROIC	19.76%
ROIC (5Y)	20.52%
SBC / revenue	1.29%
Tax / revenue	4.05%

Metric

Value

EBIT margin

33.4%

EBITDA margin

45.33%

Effective tax rate

15.01%

FCF margin

25.67%

Gross margin

71.89%

Operating margin

33.4%

Pretax margin

27%

Profit margin

22.95%

Profit per employee

ARS 411.2M

Profitable quarters

Profitable years

Revenue per employee

ARS 1.8B

ROA

8.67%

ROA (5Y)

8.22%

ROCE

18.14%

ROE

91.47%

ROE (5Y)

101.82%

ROIC

19.76%

ROIC (5Y)

20.52%

SBC / revenue

1.29%

Tax / revenue

4.05%

Metric	Value
EPS growth	31.6%
EPS growth (Q)	64.91%
EPS growth (QoQ)	30.84%
EPS growth 10Y	5.12%
EPS growth 3Y	2.72%
EPS growth 5Y	10.3%
EPS growth quarters	6
EPS growth years	1
FCF growth	-4.06%
FCF growth (Q)	82.58%
FCF growth (QoQ)	136.22%
FCF growth 3Y	1.66%
FCF growth 5Y	2.72%
Gross profit growth	13.09%
Gross profit growth (Q)	12.23%
Gross profit growth 3Y	11.58%
Gross profit growth 5Y	7.36%
Net income growth	32.09%
Net income growth (Q)	65.85%
Net income growth (QoQ)	30.57%
Net income growth 3Y	3.09%
Net income growth 5Y	8.76%
Net income growth quarters	6
Net income growth years	1
OCF growth	3.87%
OCF growth (Q)	75.53%
OCF growth (QoQ)	82.82%
OCF growth 10Y	2.7%
OCF growth 3Y	4.93%
OCF growth 5Y	5.48%
Operating income growth	19.55%
Operating income growth (Q)	19.33%
Operating income growth 3Y	8.67%
Operating income growth 5Y	6.56%
Revenue growth	9.1%
Revenue growth (Q)	9.53%
Revenue growth (QoQ)	16.66%
Revenue growth 10Y	5.42%
Revenue growth 3Y	12.74%
Revenue growth 5Y	8.37%
Revenue growth quarters	13
Revenue growth years	6

Metric

Value

EPS growth

31.6%

EPS growth (Q)

64.91%

EPS growth (QoQ)

30.84%

EPS growth 10Y

5.12%

EPS growth 3Y

2.72%

EPS growth 5Y

10.3%

EPS growth quarters

EPS growth years

FCF growth

-4.06%

FCF growth (Q)

82.58%

FCF growth (QoQ)

136.22%

FCF growth 3Y

1.66%

FCF growth 5Y

2.72%

Gross profit growth

13.09%

Gross profit growth (Q)

12.23%

Gross profit growth 3Y

11.58%

Gross profit growth 5Y

7.36%

Net income growth

32.09%

Net income growth (Q)

65.85%

Net income growth (QoQ)

30.57%

Net income growth 3Y

3.09%

Net income growth 5Y

8.76%

Net income growth quarters

Net income growth years

OCF growth

3.87%

OCF growth (Q)

75.53%

OCF growth (QoQ)

82.82%

OCF growth 10Y

2.7%

OCF growth 3Y

4.93%

OCF growth 5Y

5.48%

Operating income growth

19.55%

Operating income growth (Q)

19.33%

Operating income growth 3Y

8.67%

Operating income growth 5Y

6.56%

Revenue growth

9.1%

Revenue growth (Q)

9.53%

Revenue growth (QoQ)

16.66%

Revenue growth 10Y

5.42%

Revenue growth 3Y

12.74%

Revenue growth 5Y

8.37%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	ARS -3.4T
Depreciation and amortization	ARS 7T
EBIT	ARS 18.9T
EBITDA	ARS 25.6T
EPS	ARS 827.13
Financing cash flow	ARS -6.1T
Free cash flow	ARS 15.1T
Free cash flow minus SBC	ARS 14.3T
Gross profit	ARS 40.6T
Income taxes	ARS 2.3T
Investing cash flow	ARS -3.5T
Net borrowing	ARS 2T
Net cash flow	ARS 8.8T
Net income	ARS 13T
Operating cash flow minus SBC	ARS 17.8T
Operating income	ARS 18.9T
Revenue	ARS 56.4T
Stock-based compensation	ARS 728.9B

Metric

Value

Capital expenditures

ARS -3.4T

Depreciation and amortization

ARS 7T

EBIT

ARS 18.9T

EBITDA

ARS 25.6T

EPS

ARS 827.13

Financing cash flow

ARS -6.1T

Free cash flow

ARS 15.1T

Free cash flow minus SBC

ARS 14.3T

Gross profit

ARS 40.6T

Income taxes

ARS 2.3T

Investing cash flow

ARS -3.5T

Net borrowing

ARS 2T

Net cash flow

ARS 8.8T

Net income

ARS 13T

Operating cash flow minus SBC

ARS 17.8T

Operating income

ARS 18.9T

Revenue

ARS 56.4T

Stock-based compensation

ARS 728.9B

Metric	Value
Altman Z-Score	1.89
Book value per share	ARS 32,030.65
Debt / EBITDA	3.27
Debt / equity	4.9
Debt / FCF	5.63
Goodwill	ARS 28.8T
Interest coverage	4.14
Long-term assets	ARS 87.8T
Long-term liabilities	ARS 85.1T
Net cash (debt)	ARS -64.2T
Net cash / market cap	-17.09%
Net debt / EBITDA	2.51
Net debt / equity	3.71
Net debt / FCF	4.26
Piotroski F-Score	8
Property, plant and equipment	ARS 13.2T
Shareholders' equity	ARS 17.3T
Tangible book value	ARS -40.7T
Tangible book value per share	ARS -75,272.59
Total assets	ARS 141.7T
Total cash	ARS 20.7T
Total debt	ARS 84.9T
Total liabilities	ARS 124.4T
WACC	6.13%

Metric

Value

Altman Z-Score

1.89

Book value per share

ARS 32,030.65

Debt / EBITDA

3.27

Debt / equity

4.9

Debt / FCF

5.63

Goodwill

ARS 28.8T

Interest coverage

4.14

Long-term assets

ARS 87.8T

Long-term liabilities

ARS 85.1T

Net cash (debt)

ARS -64.2T

Net cash / market cap

-17.09%

Net debt / EBITDA

2.51

Net debt / equity

3.71

Net debt / FCF

4.26

Piotroski F-Score

Property, plant and equipment

ARS 13.2T

Shareholders' equity

ARS 17.3T

Tangible book value

ARS -40.7T

Tangible book value per share

ARS -75,272.59

Total assets

ARS 141.7T

Total cash

ARS 20.7T

Total debt

ARS 84.9T

Total liabilities

ARS 124.4T

WACC

6.13%

Metric	Value
Asset turnover	0.42
Current assets	ARS 53.9T
Current liabilities	ARS 39.3T
Current ratio	1.37
Inventory turnover	1.67
Net working capital	ARS 1.4T
Quick ratio	0.95
Working capital	ARS 14T
Working capital turnover	7,181.74

Metric

Value

Asset turnover

0.42

Current assets

ARS 53.9T

Current liabilities

ARS 39.3T

Current ratio

1.37

Inventory turnover

1.67

Net working capital

ARS 1.4T

Quick ratio

0.95

Working capital

ARS 14T

Working capital turnover

7,181.74

Metric	Value
Buyback yield / dilution	-0.46%
Dividend growth	34.03%
Dividend growth (10Y)	76.59%
Dividend growth (3Y)	93.36%
Dividend growth (5Y)	89.02%
Dividend growth years	14
Dividend payment date	2026-09-11
Dividend payment years	16
Dividend payout frequency	Quarterly
Dividend per share	ARS 306.73
Dividend yield	1.23%
Ex-dividend date	2026-08-21
Last dividend	ARS 81.67
Payout ratio	60.45%
Shareholder yield	0.77%

Metric

Value

Buyback yield / dilution

-0.46%

Dividend growth

34.03%

Dividend growth (10Y)

76.59%

Dividend growth (3Y)

93.36%

Dividend growth (5Y)

89.02%

Dividend growth years

Dividend payment date

2026-09-11

Dividend payment years

Dividend payout frequency

Quarterly

Dividend per share

ARS 306.73

Dividend yield

1.23%

Ex-dividend date

2026-08-21

Last dividend

ARS 81.67

Payout ratio

60.45%

Shareholder yield

0.77%

Metric	Value
150-day SMA	ARS 19,495.53
1D price change	1.1%
1M price change	10.2%
1M total return	10.2%
1W price change	3.75%
1W total return	3.75%
1Y price change	62.11%
1Y return CAGR	65.23%
1Y total return	65.17%
20-day SMA	ARS 22,960.50
200-day SMA	ARS 19,049.85
3M price change	23.08%
3M total return	23.76%
3Y price change	214.55%
3Y return CAGR	49.03%
3Y total return	231.09%
50-day SMA	ARS 22,438.60
50-day SMA vs 200-day SMA	50over200
52-week high	ARS 25,140.00
52-week high date	2026-10-26
52-week low	ARS 12,320.00
52-week low date	2025-10-27
5Y price change	1,656.45%
5Y return CAGR	79.97%
5Y total return	1,787.17%
6M price change	42.76%
6M total return	44.21%
All-time high	ARS 25,140.00
All-time high date	2026-10-26
All-time low	ARS 273.67
All-time low date	2019-07-31
Average true range (ATR)	ARS 602.51
Average volume	2.6K
Beta (5Y)	0.41
Change from 52-week high	-0.91%
Change from 52-week low	102.19%
Change from all-time high	-1.99%
Change from all-time low	8,903.64%
Change from open	2.38%
Day's gap	-1.26%
Dollar volume	ARS 25.1M
High price	ARS 25,120.00
Low price	ARS 24,330.00
Monthly RSI	77.34
Open price	ARS 24,330.00
Position in 52-week range	73.42%
Previous close	ARS 24,640.00
Price vs 150-day SMA	26.39%
Price vs 20-day SMA	7.31%
Price vs 200-day SMA	29.34%
Price vs 50-day SMA	9.81%
Relative volume	0.38
RSI	67.52
Sharpe ratio	1.67
Sharpe ratio (3Y)	1.23
Sharpe ratio (5Y)	1.67
Sortino ratio	2.7
Sortino ratio (3Y)	1.96
Sortino ratio (5Y)	2.71
Volume	1K
Weekly RSI	68.84
YTD price change	47.81%
YTD total return	49.94%

Metric

Value

150-day SMA

ARS 19,495.53

1D price change

1.1%

1M price change

10.2%

1M total return

10.2%

1W price change

3.75%

1W total return

3.75%

1Y price change

62.11%

1Y return CAGR

65.23%

1Y total return

65.17%

20-day SMA

ARS 22,960.50

200-day SMA

ARS 19,049.85

3M price change

23.08%

3M total return

23.76%

3Y price change

214.55%

3Y return CAGR

49.03%

3Y total return

231.09%

50-day SMA

ARS 22,438.60

50-day SMA vs 200-day SMA

50over200

52-week high

ARS 25,140.00

52-week high date

2026-10-26

52-week low

ARS 12,320.00

52-week low date

2025-10-27

5Y price change

1,656.45%

5Y return CAGR

79.97%

5Y total return

1,787.17%

6M price change

42.76%

6M total return

44.21%

All-time high

ARS 25,140.00

All-time high date

2026-10-26

All-time low

ARS 273.67

All-time low date

2019-07-31

Average true range (ATR)

ARS 602.51

Average volume

2.6K

Beta (5Y)

0.41

Change from 52-week high

-0.91%

Change from 52-week low

102.19%

Change from all-time high

-1.99%

Change from all-time low

8,903.64%

Change from open

2.38%

Day's gap

-1.26%

Dollar volume

ARS 25.1M

High price

ARS 25,120.00

Low price

ARS 24,330.00

Monthly RSI

77.34

Open price

ARS 24,330.00

Position in 52-week range

73.42%

Previous close

ARS 24,640.00

Price vs 150-day SMA

26.39%

Price vs 20-day SMA

7.31%

Price vs 200-day SMA

29.34%

Price vs 50-day SMA

9.81%

Relative volume

0.38

RSI

67.52

Sharpe ratio

1.67

Sharpe ratio (3Y)

1.23

Sharpe ratio (5Y)

1.67

Sortino ratio

2.7

Sortino ratio (3Y)

1.96

Sortino ratio (5Y)

2.71

Volume

Weekly RSI

68.84

YTD price change

47.81%

YTD total return

49.94%

Metric	Value
Float	539.2M
Shares change (QoQ)	0%
Shares change (YoY)	0.46%
Shares held by insiders	0.17%
Shares held by institutions	83.8%
Short ratio	4.8 days

Metric

Value

Float

539.2M

Shares change (QoQ)

Shares change (YoY)

0.46%

Shares held by insiders

0.17%

Shares held by institutions

83.8%

Short ratio

4.8 days

BCBA/AMGN (BCBA/AMGN)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/AMGN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/AMGN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/AMGN

Frequently asked questions